State of the art in intravaginal ring technology for topical prophylaxis of HIV infection.
about
Quantitative analysis of microbicide concentrations in fluids, gels and tissues using confocal Raman spectroscopyEngineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancyThe Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product DevelopmentIntravaginal rings as delivery systems for microbicides and multipurpose prevention technologies."Set it and forget it": women's perceptions and opinions of long-acting topical vaginal gelsSustained delivery of commensal bacteria from pod-intravaginal rings.Functionalization of ethylene vinyl acetate with antimicrobial chlorhexidine hexametaphosphate nanoparticles.An interdisciplinary framework for measuring and supporting adherence in HIV prevention trials of ARV-based vaginal ringsDevelopment of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine.An intravaginal ring for the sustained delivery of antibodies.A polyvalent Clade B virus-like particle HIV vaccine combined with partially protective oral preexposure prophylaxis prevents simian-human immunodeficiency virus Infection in macaques and primes for virus-amplified immunityTenofovir disoproxil fumarate intravaginal ring protects high-dose depot medroxyprogesterone acetate-treated macaques from multiple SHIV exposures.An intravaginal ring that releases the NNRTI MIV-150 reduces SHIV transmission in macaquesIntravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infectionAcceptability of the Nestorone®/ethinyl estradiol contraceptive vaginal ring: development of a model; implications for introductionMulticompartmental Pharmacokinetic Model of Tenofovir Delivery to the Rectal Mucosa by an Enema.A perspective on progress and gaps in HIV prevention scienceSafety and pharmacokinetics of intravaginal rings delivering tenofovir in pig-tailed macaques.A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis.In search of the optimal delivery method for anti-HIV microbicides: are intravaginal rings the way forward?Controlling the hydration rate of a hydrophilic matrix in the core of an intravaginal ring determines antiretroviral releaseEngineering and characterization of simplified vaginal and seminal fluid simulants.Drug delivery strategies and systems for HIV/AIDS pre-exposure prophylaxis and treatment.Pharmacokinetics of a multipurpose pod-intravaginal ring simultaneously delivering five drugs in an ovine model.Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges.Clinical use of vaginal or rectally applied microbicides in patients suffering from HIV/AIDS.Vaginally delivered tenofovir disoproxil fumarate provides greater protection than tenofovir against genital herpes in a murine model of efficacy and safety.Impact of the Dapivirine Vaginal Ring on Sexual Experiences and Intimate Partnerships of Women in an HIV Prevention Clinical Trial: Managing Ring Detection and Hot Sex.Women and ARV-based prevention: opportunities and challenges.
P2860
Q28538105-947E65B3-157E-446C-9FE5-9821676160EAQ28540419-61548B91-BA95-4757-B87A-34728BE316B0Q28551783-92609226-4D98-4EFA-8F15-53045B9BE21AQ30447923-99B5ED8C-023F-4339-8C4E-3FEF7BCA7C23Q33601303-CCA7E2A1-7CEB-4DDF-98B4-B812C4178435Q33622882-DD1FF866-F116-4E80-94F4-8D9C8288E7E7Q34148982-37E1AF77-A982-4D8C-AE28-957FD675701FQ34180658-DC2B0E65-98FD-4395-AE43-576D1D2CE391Q34353780-E2F816AE-543E-4EA7-AA72-3F6DC7CF9F43Q34389166-8EF9081E-0098-4EC5-BAB1-31014760A462Q34399535-4F1EC370-0834-4832-9088-CB874CE3FB53Q34673931-9019C612-DA11-4988-BF92-A7491A336040Q35345363-7E54C226-49D0-4A23-AE7D-36B627CDA1D7Q36018953-73A9C83B-CDD6-4FFF-A835-17A685A09570Q36108786-B5D5005C-0468-42F8-8487-061731FEDC1DQ36257669-BAECC484-157F-4A68-B480-D9430024342AQ36358897-95498188-7308-4D3B-82E6-1FC11821C698Q36364164-6614625B-AB51-440E-BB5A-7ECACF36C730Q36396237-4477CE15-29CD-4A34-93E9-B6D92C813044Q36630547-28F94538-A1AA-4C59-A65A-7610740B9560Q36666807-C1B921C4-5F32-4C4D-B59A-AEE25DFBDAC3Q36890847-CA33614B-F254-47CC-9B79-55986EE993E3Q36934918-821291D4-819D-4CF2-91B3-D1C0D9049970Q37036412-9874FF73-5EAF-4D3D-B9E4-4B4D1DE72FA4Q37218578-E4DFD990-CC13-4C69-902D-EDE4FC062779Q37255082-2351E08A-5F26-4B16-BA40-63C7BFC91FA8Q37544735-3AB67AAA-5CCA-43A7-B985-4BD1D34B82D5Q46205436-38CECA9E-1E08-4C96-BBF8-585190A0E23DQ46553256-3696A663-EF1A-4460-8C76-32EE5C6ACBE5
P2860
State of the art in intravaginal ring technology for topical prophylaxis of HIV infection.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
State of the art in intravagin ...... prophylaxis of HIV infection.
@en
State of the art in intravagin ...... prophylaxis of HIV infection.
@nl
type
label
State of the art in intravagin ...... prophylaxis of HIV infection.
@en
State of the art in intravagin ...... prophylaxis of HIV infection.
@nl
prefLabel
State of the art in intravagin ...... prophylaxis of HIV infection.
@en
State of the art in intravagin ...... prophylaxis of HIV infection.
@nl
P2093
P1433
P1476
State of the art in intravaginal ring technology for topical prophylaxis of HIV infection
@en
P2093
Justin T Clark
Patrick F Kiser
Todd J Johnson
P577
2012-01-01T00:00:00Z